Gunjan Mandal

Position: Project Technical Support-I No. of posts: 01 Remuneration: Rs. 18,000/- + 20% HRA per month We are looking for motivated candidates who wants to contribute to clinical cancer immunology research. For more details, click the above-mentioned link.

TII Lab at BRIC-ILS will recruit three (03) research personnel in an ICMR-funded project. Interested candidates HURRY UP lnkd.in/g4qk8B9b Original recruitment notice: lnkd.in/gptQU4nE

Position: Senior Project Assistant No. of posts: 02 Remuneration: Rs. 30,600/- per month (consolidated) We are looking for candidates having experience in animal cell culture, mice handling and molecular biology techniques. For more details, click on the above-mentioned link.

It was absolute relishing to attend and deliver an invited talk at the 5th Global Cancer Consortium (GCC) 2025 at the Amity University, Noida. Thanks to the organizers for the amazing arrangement. #amityuniversity #GCC2025

Tumor Immunology and Immunotherapeutics Lab at the BRIC-ILS, Bhubaneswar will recruit one JRF on a SERB-funded project, focused on antibody-based cancer immunotherapy. Interested are encouraged to apply through the website ils.res.in.

Our recent work, published in Immunity (PMID: 37909039) has been covered by the AACR blog. Proud moment for the whole team. @Saturnino_Arrua @carmen_anadon @subir_biswas88

Tumor Immunology and Immuno-therapeutics Lab at the BRIC-ILS, Bhubaneswar will recruit one JRF on a SERB-funded project, focused on antibody-based cancer immunotherapy. Interested are encouraged to apply through the website ils.res.in. #JRF_GMLab #Cancerimmunotherapy

Cancer Immune-environment and therapeutics lab (Biswas Lab) at ACTREC will host one DBT-RA application of a motivated candidate who is willing to pursue research in the area of tumor Immunology and Immunotherapy. Please email at sbiswas@actrec.gov.in acrobat.adobe.com/id/urn:aaid:sc…

The research projects of the Tumor Immunology Lab are focused to explore mechanistic insights of spontaneous anti-tumor immune responses and developing novel immunotherapeutic strategies against epithelial malignancies.

Tumor Immunology and Immuno-Therapeutics Lab at the @DBT_ILS, Bhubaneswar is looking forward to recruiting one PhD-JRF through the upcoming PhD entrance. #PhD_in_Cancer_Immunotherapy #PhD_in_Tumor_Immunology #PhD_program_ILS #Tumor_Immunology_and_Immunotherapeutics_Lab_ILS

Once again, our novel finding of intracellular targeting of mutated oncodrivers in our recent publication in #Immunity has been highlighted. This time it is covered in #CancerDiscovery @CD_AACR @Saturnino_Arrua @CarmenAnadon @subir_biswas88

Dimeric IgA undergoes transcytosis through PIGR+ epithelial cancer cells and can be engineered for the specific targeting of intracellular mutated oncodrivers to expels them from cytoplasm & promote anti-tumor immunity @ImmunityCP @Saturnino_Arrua cell.com/immunity/fullt…

Our recently published article #Immunity, showing specific targeting of intracellular mutated oncodrivers has been very nicely summarized in a preview by @maijahollmen and team

@maijahollmen @subir_biswas88 @ImmunityCP Thank you, Dr Hallmen for nicely putting up the story in the commentary!

Amazing study by @subir_biswas88 et al. in @ImmunityCP Shorter version here in preview 👉🏻Dimeric IgA specifically disables intracellular mutated oncodrivers: Immunity cell.com/immunity/fullt…

For the first time, we show in our recently published article in #Immunity that antigen-specific dimeric IgA antibodies can penetrate PIGR+ epithelial cancer cells and could target intracellular antigens, enabling new potential immunotherapy opportunities. cell.com/immunity/fullt…

If you’re headed to the #AACR23 plenary session on Embracing #Immune Ecosystems, be sure to read this article by speaker Jose Conejo-Garcia: IgA-Dominated Humoral Immune Responses Govern Patients’ Outcome in #EndometrialCancer— bit.ly/3UNCeIM